Findings

What do systematic reviews say?

4 questions · 4 findings · 3 reviews · Hepato-Biliary

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2 · 50%GRADE not reported 0 · 0%Very low 2 · 50%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Interferon vs no intervention

Short‐term mortality · people with acute HBV infection

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for acute hepatitis B infection 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Deep neuromuscular blockade (NMB) vs moderate NMB

All‐cause mortality short‐term · adults undergoing intra‐ and transperitoneal laparoscopic procedures

It is very uncertain whether summary of findings table ‐ Deep neuromuscular blockade (NMB) changes all‐cause mortality short‐term compared with moderate NMB (very low certainty).

1 finding from 1 review

Deep neuromuscular blockade in adults undergoing an abdominal laparoscopic procedure 2024 · Cochrane Headline outcomes only
Peto OR 7.22 [0.45, 115.43]
12 studies · 1390 participants
Very low

Lamivudine vs no intervention

Short‐term mortality (< 1 year) · people with acute HBV infection

It is very uncertain whether lamivudine changes short‐term mortality (< 1 year) compared with no intervention (very low certainty).

1 finding from 1 review

Pharmacological interventions for acute hepatitis B infection 2017 · Cochrane Headline outcomes only
OR 1.29 [0.33, 4.99]
2 studies · 250 participants
Very low

Chemotherapy vs no chemotherapy

Short‐term and medium‐term mortality · people with intermediate‐stage hepatocellular carcinoma

The review found no eligible studies for this question.

1 finding from 1 review

Management of people with intermediate‐stage hepatocellular carcinoma 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found